1Lin L,Ling B D, Li XZ. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial isolates of Acinetobacter baumannii Acinetobacter calcoaceticus complex[J]. Int J Antimicrob Agents, 2009,33 (1) : 27-32.
2Poole K. Efflux pumps as antimicrobial resistance mechanisms[J]. Ann Med,2007,39(3) : 162-176.
1Kanafani ZA, Kara L, Hayek S, et al. Ventilator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect Control Hosp Epidemiol, 2003, 24(11) : 864-869.
2Hsueh PR, Teng LJ, Chen CY, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis, 2002, 8(8) : 827-832.
3Marchand I, Damier-Piolle L, Courvalin P, et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother, 2004,48 (9) : 3298-3304.
4Magnet S, Courvalin P, Lambert T. Resistanee-nodulation-eell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother, 2001,45 (12) : 3375-3380.
5Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet, 2006, 2 ( 1 ) : e70062-e70072.
6Adams MD, Goglin K, Molyneaux N, et al. Comparative gertome sequence analysis of muhidrug-resistant Acinetobacter baumannii. J Bacteriol, 2008, 190(24) : 8053-8064.
7FRANKARD J, RODRIGUEZ-VILLALOBOS H, STRUELENS M J, et al. Haemophilus parainfluenzae: an underdiagnosed pathogen of biliary tract infections? [J]. Eur J Clin Microbiol Infect Dis,2004,23( 1 ) :46- 48.
9HIGGINS P G, HILMAR WISPLINGHOFF, DANUTA STEFANIK, et al. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobater baumannii [ J ]. J Antimicrob Chemother,2004,54(4) :821-823.
10LI Xian-zhi ,ZHANG Li, N IKAIDO H. Efflux pump-medicated intrinsic drug resistance in Mycobacterium smegmatis [ J ]. Antimicrob Agents Chemother ,2004,48 (7) :2415-2423.
5Zheng W, Yuan S, Li L. Analysis of hospital departmen- tal distribution and antibiotic susceptibility of acineto- bacter isolated from sputum samples[J]. Am J Infect Con- trol,2013,41(8) :e73.
6Wiwanitkit V.Multidrug-resistant Acinetobacter baumannii infection in the intensive care unit[J].Korean J Anesthesiol,2014,67(2):153.
7Villar M,Cano ME,Gato E,et al.Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection:a reappraisal[J].Medicine,2014,93(5):202.
8Sun CC,Hao JW,Dou MQ,et al.Mutant prevention concentrations of levofloxacin,pazufloxacin and ciprofloxacin for A.baumannii and mutations in gyr A and par C genes[J].J Antibioti,2014,doi:10.1038/ja.2014.150.
9Clinical and Laboratory Standards Institute.Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically;approved standard-ninth edition[S].2012-01.
10Tan TY,Lim TP,Lee WHL,et al.In vitro antibiotic synergy in extensively drug-resistant acinetobacter baumannii:the effect of testing by time-kill,checkerboard,and etest methods[J].Antimicrob Agents Chemother,2011,55(1):436.
